BRABEC, Viktor. Chemistry and structural biology of 1,2-interstrand adducts of cisplatin. In Platinum Based Drugs in Cancer Therapy. Totowa, New Jersey, USA: Humana Press, Inc, 2000, p. 37-61. ISBN 0-89603-599-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chemistry and structural biology of 1,2-interstrand adducts of cisplatin
Authors BRABEC, Viktor.
Edition Totowa, New Jersey, USA, Platinum Based Drugs in Cancer Therapy, p. 37-61, 2000.
Publisher Humana Press, Inc
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 10610 Biophysics
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14310/00:00003312
Organization unit Faculty of Science
ISBN 0-89603-599-9
Changed by Changed by: prof. RNDr. Viktor Brabec, DrSc., učo 46787. Changed: 27/2/2001 09:46.
Abstract
Formation of DNA interstrand cross-links of different platinum antitumor compounds is challenging to be understood, not only from the mechanistic view, but also from the therapeutic one. Comprehension of the physiological roles of DNA interstrand cross-links of antitumor platinum compounds in functions of tumor cells requires integration of inorganic chemistry, molecular and cell biology and pharmacology. A coordinated effort in the research of interstrand cross-links induced by genotoxic agents is underway to resolve remaining problems of their structures, cellular processing and biological significance. This review article summarizes a current knowledge on structure, biochemistry and biological impact of interstrand cross-links formed in DNA by antitumor cisplatin.
Links
GA305/99/0695, research and development projectName: Ovlivnění konformace DNA protinádorově účinnými komplexy kovů. Vztah k vývoji nových cytostatik.
PrintDisplayed: 11/10/2024 20:30